CRMD
CorMedix Inc
NASDAQ: CRMD · HEALTHCARE · BIOTECHNOLOGY
$7.48
-1.19% today
Updated 2026-04-29
Market cap
$586.55M
P/E ratio
3.64
P/S ratio
1.88x
EPS (TTM)
$2.04
Dividend yield
—
52W range
$6 – $17
Volume
1.3M
CorMedix Inc (CRMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $2000.00 | $189274.00 | $210130.00 | $224105.00 | $329327.00 | $429797.00 | $283266.00 | $239231.00 | $190936.00 | $65408.00 | $0.00 | $43.47M | $311.71M |
| Revenue growth (YoY) | — | — | — | — | — | — | +9363.7% | +11.0% | +6.7% | +47.0% | +30.5% | -34.1% | -15.5% | -20.2% | -65.7% | -100.0% | — | +617.0% |
| Cost of revenue | $1.04M | — | — | $0.00 | $0.00 | $201605.00 | $445799.00 | $318718.00 | $366673.00 | $114964.00 | $396786.00 | $373234.00 | $204846.00 | $148938.00 | $3734.00 | $205562.00 | $3.19M | $35.96M |
| Gross profit | $-1.04M | — | — | $0.00 | $0.00 | $-199604.00 | $-256525.00 | $-108588.00 | $-142568.00 | $214363.00 | $33011.00 | $-89968.00 | $34385.00 | $41998.00 | $61674.00 | $-205562.00 | $40.28M | $275.75M |
| Gross margin | — | — | — | — | — | -9980.2% | -135.5% | -51.7% | -63.6% | 65.1% | 7.7% | -31.8% | 14.4% | 22.0% | 94.3% | — | 92.7% | 88.5% |
| R&D | $3.08M | $4.89M | $5.49M | $4.10M | $1.19M | $1.23M | $1.32M | $6.28M | $15.74M | $24.49M | $18.82M | $11.05M | $13.38M | $13.13M | $10.68M | $13.16M | $3.94M | $19.33M |
| SG&A | $4.81M | $1.17M | $3.01M | $3.15M | $1.86M | $3.49M | $7.33M | $10.26M | $8.88M | $8.65M | $8.07M | $9.87M | $13.88M | $16.35M | $20.01M | $17.69M | $29.96M | $68.22M |
| Operating income | $-4.82M | $-6.06M | $-8.51M | $-7.25M | $-3.04M | $-4.92M | $-8.90M | $-16.65M | $-24.76M | $-32.92M | $-26.86M | $-21.01M | $-27.22M | $-29.44M | $-30.62M | $-48.96M | $-22.36M | $150.14M |
| Operating margin | — | — | — | — | — | -245769.8% | -4703.3% | -7925.6% | -11048.8% | -9997.4% | -6250.4% | -7416.3% | -11378.4% | -15417.5% | -46819.9% | — | -51.4% | 48.2% |
| EBITDA | $-3.75M | $-6.04M | $-8.47M | $-7.19M | $-3.04M | $-7.68M | $-20.44M | $-18.17M | $-24.62M | $-32.97M | $-26.75M | $-20.93M | $-27.02M | $-29.38M | $-30.05M | $-46.23M | $-18.98M | $165.13M |
| EBITDA margin | — | — | — | — | — | -384177.4% | -10797.2% | -8646.3% | -10985.0% | -10012.2% | -6224.7% | -7390.4% | -11294.7% | -15385.1% | -45945.1% | — | -43.7% | 53.0% |
| EBIT | $-4.79M | $-6.05M | $-8.48M | $-7.21M | $-3.04M | $-7.69M | $-20.45M | $-18.18M | $-24.64M | $-33.01M | $-26.83M | $-21.01M | $-27.16M | $-29.55M | $-30.26M | $-46.30M | $-19.29M | $150.14M |
| Interest expense | $4.21M | $2.07M | $3.09M | $12037.00 | $382936.00 | $1.44M | $2087.00 | $3964.00 | $1311.00 | $5619.00 | $1873.00 | $787488.00 | $33226.00 | $15943.00 | $26515.00 | $34296.00 | $36405.00 | $2.78M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.00M | $-8.12M | $-10.91M | $-6.71M | $-3.43M | $-9.13M | $-20.45M | $-18.19M | $-24.64M | $-33.01M | $-26.83M | $-16.43M | $-22.03M | $-28.21M | $-29.70M | $-46.34M | $-17.93M | $163.06M |
| Net income growth (YoY) | — | +9.7% | -34.3% | +38.5% | +49.0% | -166.6% | -123.9% | +11.1% | -35.5% | -33.9% | +18.7% | +38.8% | -34.0% | -28.1% | -5.3% | -56.0% | +61.3% | +1009.4% |
| Profit margin | — | — | — | — | — | -456654.9% | -10806.3% | -8655.4% | -10996.5% | -10023.4% | -6242.4% | -5801.3% | -9207.7% | -14774.7% | -45409.9% | — | -41.2% | 52.3% |